These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 29409146)
1. Reliability and Validity of Three Versions of the Brief Fear of Negative Evaluation Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study. Fox RS; Kwakkenbos L; Carrier ME; Mills SD; Gholizadeh S; Jewett LR; Roesch SC; Merz EL; Assassi S; Furst DE; Gottesman K; Mayes MD; Thombs BD; Malcarne VL; Arthritis Care Res (Hoboken); 2018 Nov; 70(11):1646-1652. PubMed ID: 29409146 [TBL] [Abstract][Full Text] [Related]
2. Shortening patient-reported outcome measures through optimal test assembly: application to the Social Appearance Anxiety Scale in the Scleroderma Patient-centered Intervention Network Cohort. Harel D; Mills SD; Kwakkenbos L; Carrier ME; Nielsen K; Portales A; Bartlett SJ; Malcarne VL; Thombs BD; BMJ Open; 2019 Feb; 9(2):e024010. PubMed ID: 30798308 [TBL] [Abstract][Full Text] [Related]
3. Social anxiety and fear of negative evaluation: construct validity of the BFNE-II. Carleton RN; Collimore KC; Asmundson GJ J Anxiety Disord; 2007; 21(1):131-41. PubMed ID: 16675196 [TBL] [Abstract][Full Text] [Related]
4. Validation of the Social Appearance Anxiety Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study. Mills SD; Kwakkenbos L; Carrier ME; Gholizadeh S; Fox RS; Jewett LR; Gottesman K; Roesch SC; Thombs BD; Malcarne VL; Arthritis Care Res (Hoboken); 2018 Oct; 70(10):1557-1562. PubMed ID: 29342510 [TBL] [Abstract][Full Text] [Related]
5. Psychometric properties of the Chinese version of the fear of negative evaluation scale-brief (BFNE) and the BFNE-straightforward for middle school students. Wei J; Zhang C; Li Y; Xue S; Zhang J PLoS One; 2015; 10(3):e0115948. PubMed ID: 25799570 [TBL] [Abstract][Full Text] [Related]
6. Validity, Reliability, and Differential Item Functioning of English and French Versions of the 10-Item Connor-Davidson Resilience Scale in Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study. Neyer MA; Henry RS; Carrier ME; Kwakkenbos L; Wojeck RK; Gietzen A; Gottesman K; Guillot G; Lawrie-Jones A; Mayes MD; Mouthon L; Nielson WR; Richard M; Worron-Sauvé M; Harel D; Malcarne VL; Bartlett SJ; Thombs BD; Arthritis Care Res (Hoboken); 2023 Nov; 75(11):2369-2378. PubMed ID: 37128826 [TBL] [Abstract][Full Text] [Related]
7. Psychometric evaluation of the Iranian version of brief fear of negative evaluation scale-straightforward item (BFNE-S): A validation study. Tavoli A; Montazeri A Med J Islam Repub Iran; 2020; 34():29. PubMed ID: 32617268 [No Abstract] [Full Text] [Related]
8. The validity and reliability of the Turkish version of the Brief Fear of Negative Evaluation Scale - straight forwardly in patients with systemic sclerosis. Kabul EG; Demir P; Ulutas F; Yenil S; Calik BB; Cobankara V Malawi Med J; 2023 Sep; 35(3):163-169. PubMed ID: 38362287 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Satisfaction with Appearance Scale and Its Short Form in Systemic Sclerosis: Analysis from the UCLA Scleroderma Quality of Life Study. Mills SD; Fox RS; Merz EL; Clements PJ; Kafaja S; Malcarne VL; Furst DE; Khanna D J Rheumatol; 2015 Sep; 42(9):1624-30. PubMed ID: 26034157 [TBL] [Abstract][Full Text] [Related]
10. Factor structure and convergent validity of the Derriford Appearance Scale-24 using standard scoring versus treating 'not applicable' responses as missing data: a Scleroderma Patient-centered Intervention Network (SPIN) cohort study. Merz EL; Kwakkenbos L; Carrier ME; Gholizadeh S; Mills SD; Fox RS; Jewett LR; Williamson H; Harcourt D; Assassi S; Furst DE; Gottesman K; Mayes MD; Moss TP; Thombs BD; Malcarne VL; BMJ Open; 2018 Mar; 8(3):e018641. PubMed ID: 29511009 [TBL] [Abstract][Full Text] [Related]
11. Development and validation of the brief-satisfaction with appearance scale for systemic sclerosis. Jewett LR; Hudson M; Haythornthwaite JA; Heinberg L; Wigley FM; Baron M; Thombs BD; Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1779-86. PubMed ID: 20665750 [TBL] [Abstract][Full Text] [Related]
12. Validation of the COVID-19 Fears Questionnaires for Chronic Medical Conditions: A Scleroderma Patient-centered Intervention Network COVID-19 Cohort study. Wu Y; Kwakkenbos L; Henry RS; Tao L; Harb S; Bourgeault A; Carrier ME; Levis B; Sun Y; Bhandari PM; Carboni-Jiménez A; Gagarine M; He C; Krishnan A; Negeri ZF; Neupane D; Mouthon L; Bartlett SJ; Benedetti A; Thombs BD; ; J Psychosom Res; 2020 Dec; 139():110271. PubMed ID: 33096402 [TBL] [Abstract][Full Text] [Related]
13. Measurement equivalence of the English and French versions of the self-efficacy to manage chronic disease scale: a Scleroderma Patient-Centered Intervention Network (SPIN) study. Choi AK; Rapoport CS; Kwakkenbos L; Carrier ME; Gottesman K; Roesch SC; Harel D; Thombs BD; Malcarne VL; Qual Life Res; 2024 Mar; 33(3):843-851. PubMed ID: 38191792 [TBL] [Abstract][Full Text] [Related]
14. Development of a new patient-reported outcome measure to assess activities and participation in people with systemic sclerosis: the Cochin 17-item Scleroderma Functional scale. Daste C; Abdoul H; Foissac F; Papelard A; Alami S; Kwakkenbos L; Carrier ME; Lefèvre-Colau MM; Thombs BD; Poiraudeau S; Rannou F; Mouthon L; Nguyen C Br J Dermatol; 2020 Oct; 183(4):710-718. PubMed ID: 32017013 [TBL] [Abstract][Full Text] [Related]
15. Validation of the Self-Efficacy for Managing Chronic Disease Scale: A Scleroderma Patient-Centered Intervention Network Cohort Study. Riehm KE; Kwakkenbos L; Carrier ME; Bartlett SJ; Malcarne VL; Mouthon L; Nielson WR; Poiraudeau S; Nielsen K; Baron M; Frech T; Hudson M; Pope J; Sauve M; Suarez-Almazor ME; Wigley FM; Thombs BD; Arthritis Care Res (Hoboken); 2016 Aug; 68(8):1195-200. PubMed ID: 26619042 [TBL] [Abstract][Full Text] [Related]
16. The Brief Fear of Negative Evaluation Scale (BFNE): translation and validation study of the Iranian version. Tavoli A; Melyani M; Bakhtiari M; Ghaedi GH; Montazeri A BMC Psychiatry; 2009 Jul; 9():42. PubMed ID: 19589161 [TBL] [Abstract][Full Text] [Related]
17. Convergent, incremental, and criterion-related validity of multi-informant assessments of adolescents' fears of negative and positive evaluation. Karp JN; Makol BA; Keeley LM; Qasmieh N; Deros DE; Weeks JW; Racz SJ; Lipton MF; Augenstein TM; De Los Reyes A Clin Psychol Psychother; 2018 Mar; 25(2):217-230. PubMed ID: 29148601 [TBL] [Abstract][Full Text] [Related]
18. Validation of the Body Concealment Scale for Scleroderma (BCSS): Replication in the Scleroderma Patient-centered Intervention Network (SPIN) Cohort. Jewett LR; Kwakkenbos L; Carrier ME; Malcarne VL; Harcourt D; Rumsey N; Mayes MD; Assassi S; Körner A; Fox RS; Gholizadeh S; Mills SD; Fortune C; Portales A; Thombs BD; Body Image; 2017 Mar; 20():99-106. PubMed ID: 28068643 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of Measurement Properties and Differential Item Functioning in the English and French Versions of the University of California, Los Angeles, Loneliness Scale-6: A Scleroderma Patient-Centered Intervention Network (SPIN) Study. S Rapoport C; Choi AK; Kwakkenbos L; Carrier ME; Henry RS; Mouthon L; Roesch SC; Thombs BD; Malcarne VL; ; Arthritis Care Res (Hoboken); 2023 Oct; 75(10):2158-2165. PubMed ID: 36938696 [TBL] [Abstract][Full Text] [Related]
20. Empirical validation and psychometric evaluation of the Brief Fear of Negative Evaluation Scale in patients with social anxiety disorder. Weeks JW; Heimberg RG; Fresco DM; Hart TA; Turk CL; Schneier FR; Liebowitz MR Psychol Assess; 2005 Jun; 17(2):179-90. PubMed ID: 16029105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]